Bi-layer Acetaminophen Tramadol Tablet Synchronized Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Developing an extended release dosage form for a combination of acetaminophen and tramadol that achieves synchronized release of both drugs over an extended period is challenging due to differences in water solubility and absorption rates, leading to unpredictable plasma concentration fluctuations and frequent dosing requirements.
Innovation Solution
The use of a complexed tramadol material with an anionic polymer, specifically carrageenan, to create a pharmaceutical composition that exhibits coordinated sustained release, ensuring a synchronized release profile of acetaminophen and tramadol over 4 to 12 hours, achieved through a bi-layer tablet design with an immediate release layer and an extended release layer.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If immediate release dosage form is used for tramadol/APAP combination, then onset of action is fast, but dosing frequency must be frequent (every 4-6 hours)
Solution Approach 1:
The invention divides the single dosage form into two distinct layers: an immediate release layer containing APAP for rapid onset of action, and an extended release layer containing tramadol for prolonged duration of action. This segmentation allows each layer to independently control the release profile of its respective drug, resolving the contradiction between fast onset and long duration.
2Duration of action of moving object
If extended release dosage form is used for tramadol, then duration of action is extended, but release profile becomes unpredictable due to solubility differences
Solution Approach 1:
The invention applies different release characteristics to different parts of the dosage form: the immediate release layer provides rapid drug delivery for quick onset, while the extended release layer provides controlled, sustained delivery for prolonged effect. Each layer is specifically designed with appropriate excipients and structure to achieve its intended release profile, making the overall system predictable and reliable.
3Ease of manufacture
If hydrophilic polymer matrix approach is used for extended release, then manufacturing is simplified, but coordinated release of APAP and tramadol is difficult to achieve
Solution Approach 1:
The invention segments the dosage form into two independent layers, each optimized for its specific drug's release characteristics. This segmentation allows each layer to be manufactured and controlled independently, achieving coordinated release profiles for APAP and tramadol while maintaining manufacturing feasibility through established tabletting techniques.
4Adaptability or versatility
If different release rates are used for APAP and tramadol, then absorption differences are accommodated, but plasma concentration fluctuations become unpredictable
Solution Approach 1:
The invention assigns different release qualities to different layers: the immediate release layer rapidly releases APAP to match its fast absorption and short half-life, while the extended release layer slowly releases tramadol to match its slower absorption and longer half-life. This localized optimization of release characteristics for each drug ensures predictable plasma concentration profiles despite their different pharmacokinetic properties.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in a sustained release of both drugs with a near-zero-order release kinetics, reducing the release rate gap and providing a consistent therapeutic effect with less frequent dosing, thus overcoming the limitations of previous formulations.
Implementation Method 1
the drug/polymer ionic interaction between tramadol and an anionic polymer provides a slow release of tramadol
Implementation Method 2
the composition exhibits coordinated sustained release upon dissolution as in oral administration in a patient
Data Source
Figure 1A~1C
Figure 2~3
Figure 4~5
AI summary
An extended release oral administered dosage form of acetaminophen and tramadol. The dosage form includes a composition of acetaminophen together with a tramadol complex formed with an anionic polymer. The tramadol complex provides sustained release of tramadol for a synchronized (coordinated) release profile of acetaminophen and tramadol.